发明名称 HYDROXYBENZAMIDDERIVATER OG DERES ANVENDELSE SOM INHIBITORER AF HSP90
摘要 The invention provides compounds of the formula (I): or salts, tautomers, solvates and N-oxides thereof; wherein R 1 is hydroxy or hydrogen; R 2 is hydroxy; methoxy or hydrogen; provided that at least one of R 1 and R 2 is hydroxy; R 3 is selected from hydrogen; halogen; cyano; optionally substituted C 1-5 hydrocarbyl and optionally substituted C 1-5 hydrocarbyloxy; R 4 is selected from hydrogen; a group -(O) n -R 7 where n is 0 or 1 and R 7 is an optionally substituted acyclic C 1-5 hydrocarbyl group or a monocyclic carbocyclic or heterocyclic group having 3 to 7 ring members; halogen; cyano; hydroxy; amino; and optionally substituted mono- or di-C 1-5 hydrocarbylamino; or R 3 and R 4 together form a monocyclic carbocyclic or heterocyclic ring of 5 to 7 ring members; and NR 5 R 6 forms an optionally substituted bicyclic heterocyclic group having 8 to 12 ring members of which up to 5 ring members are heteroatoms selected from oxygen, nitrogen and sulphur. The compounds have activity as Hsp90 inhibitors.
申请公布号 DK2332909(T3) 申请公布日期 2014.11.10
申请号 DK20110158930T 申请日期 2006.04.13
申请人 ASTEX THERAPEUTICS LIMITED 发明人 CHESSARI, GIANNI;CONGREVE, MILES STUART;NAVARRO, EVA FIGUEROA;FREDERICKSON, MARTYN;MURRAY, CHRISTOPHER;WOOLFORD, ALISON JO-ANN;CARR, MARIA GRAZIA;DOWNHAM, ROBERT;O'BRIEN, MICHAEL ALISTAIR;PHILLIPS, THERESA RACHEL;WOODHEAD, ANDREW JAMES
分类号 C07D209/44;A61K31/403;A61K31/438;A61K31/439;C07D209/08;C07D215/08;C07D401/04;C07D401/12;C07D471/04;C07D471/10;C07D491/08;C07D491/10 主分类号 C07D209/44
代理机构 代理人
主权项
地址